Overview Financials News + Filings Key Docs Ownership
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Intercure Ltd.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/14/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
07/24/2023 |
6-K
| Quarterly results |
07/11/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
06/12/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934 For the Month of June 2023 001-40614 INTERCURE LTD. 85 Medinat ha-Yehudim Street Herzliya, 4676670, Israel Tel: +972 77 460 5012 Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Exhibit Index Exhibit No. Description 99.1 Press Release dated June 9, 2023 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.",
"NEW YORK, TORONTO, and HERZLIYA, Israel — June 9, 2023" |
|
05/16/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934 For the Month of May 2023 001-40614 INTERCURE LTD. 85 Medinat ha-Yehudim Street Herzliya, 4676670, Israel Tel: +972 77 460 5012 Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Exhibit Index Exhibit No. Description 99.1 Press Release dated May 15, 2023 99.2 Management’ s Discussion and Analysis of Financial Condition and Results of Operations for the three-month period ended March 31, 2023 and 2022 99.3 Interim Condensed Consolidated Financial Statements for the period ended March 31, 2023 2 SIGNATURES...",
"InterCure Ltd.",
"Management’ s Discussion and Analysis of Financial Condition and Results of Operations for the three-month period ended March 31, 2023 and 2022",
"Interim Condensed Consolidated Financial Statements for the period ended March 31, 2023 (Unaudited)" |
|
05/01/2023 |
20-F
| Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: |
04/26/2023 |
6-K
| Quarterly results |
04/25/2023 |
6-K
| Quarterly results |
04/20/2023 |
6-K
| Quarterly results |
04/03/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
04/03/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934 For the Month of April 2023 001-40614 INTERCURE LTD. 85 Medinat ha-Yehudim Street Herzliya, 4676670, Israel Tel: +972 77 460 5012 Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ____ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ____ Exhibit Index Exhibit No. Description 99.1 Press Release dated March 31, 2023 99.2...",
"InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results",
"Management’ s Discussion and Analysis for the year ended December 31, 2022",
"Consolidated Financial Statements as of December 31, 2022",
"Annual Information Form of the Company for the year ended December 31, 2022" |
|
02/14/2023 |
6-K
| Quarterly results |
02/01/2023 |
6-K
| Quarterly results |
12/19/2022 |
6-K
| Quarterly results |
12/05/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
11/23/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
11/17/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
11/16/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
08/18/2022 |
6-K
| Quarterly results |
07/15/2022 |
6-K
| Quarterly results |
06/27/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
06/23/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
05/24/2022 |
6-K
| Quarterly results |
05/16/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
04/28/2022 |
20-F
| Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: |
04/07/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934 For the Month of April 2022 001-40614 INTERCURE LTD. 85 Medinat ha-Yehudim Street Herzliya, 4676670, Israel Tel: +972 77 460 5012 Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ____ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ____ Exhibit Index Exhibit No. Description 99.1 Annual Information Form of the Company ...",
"Annual Information Form of the Company for the year ended December 31, 2021",
"Management’ s Discussion and Analysis of Financial Condition and Results of Operations for the years ended December 31, 2021 and 2020",
"Consolidated Financial Statements for the year ended December 31, 2021",
"InterCure Reports Record Breaking Q4 and 2021 Results – Exceeded Preliminary Results" |
|
02/09/2022 |
6-K
| Quarterly results |
01/04/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
12/03/2021 |
6-K
| Quarterly results |
12/03/2021 |
6-K
| Quarterly results |
11/17/2021 |
6-K
| Quarterly results |
10/25/2021 |
6-K
| Quarterly results |
10/05/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
10/04/2021 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
|
|
|